Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37 Targeted Radioimmunotherapy in Activated B Cell like Diffuse Large B Cell Lymphoma Cell Lines

Gro Elise Rødland, PhD, Katrine Melhus, Roman Generalov, Sania Gilani, Francesco Bertoni, MD, Jostein Dahle, PhD, Randi Syljuåsen, PhD, Sebastian Patzke, PhD

Blood (2019) 134 (Supplement_1): 2574.

https://doi.org/10.1182/blood-2019-123287

Published: 2019

Journal Articles

The Transcription Repressor Gfi1 Directly Interacts With and Is Phosphorylated By Aurora A Kinase, Which Abrogates Myeloma-Induced Gfi1 Repression Of The Runx2 Promoter In Pre-Osteoblasts

Jixin Ding, PhD, Fengming Wang, PhD, ShunQian Jin, PhD, Judy Anderson, Deborah L. Galson, Ph.D., G. David Roodman, M.D., Ph.D.

Blood (2013) 122 (21): 1844.

https://doi.org/10.1182/blood.V122.21.1844.1844

Published: 2013

Journal Articles

The Transcription Repressor Gfi1 Directly Interacts With and Is Phosphorylated By Aurora A Kinase, Which Abrogates Myeloma-Induced Gfi1 Repression Of The Runx2 Promoter In Pre-Osteoblasts

Jixin Ding, PhD, Fengming Wang, PhD, ShunQian Jin, PhD, Judy Anderson, Deborah L. Galson, Ph.D., G. David Roodman, M.D., Ph.D.

Blood (2013) 122 (21): 1184.

https://doi.org/10.1182/blood.V122.21.1184.1184

Published: 2013

Journal Articles

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

Soo Jeong Kim, M.D., Haeng Im Jung, Hye Won Lee, M.D., Jin Seok Kim, M.D., Ph.D., Yoo-Hong Min, M.D., Ph.D.

Blood (2008) 112 (11): 2644.

https://doi.org/10.1182/blood.V112.11.2644.2644

Published: 2008

Journal Articles

Inhibition of Multiple Myeloma Tumor Growth and FGFR3 by the Aurora-Angiogenesis Inhibitor ENMD-981693.

Todd A. Hembrough, Xiaoru Chen, Patricia A. Burke, Glenn M. Swartz, Kathleen Bengali, Richard Brokx, Theresa M. LaVallee, Mark R. Bray

Blood (2007) 110 (11): 1209.

https://doi.org/10.1182/blood.V110.11.1209.1209

Published: 2007

Journal Articles

Thrombophilic Patients with Migraines Have a High Incidence of Antiphospholipid Antibodies.

Zella Rose Zeigler, MD, Andrea L. Cortese Hassett, PhD

Blood (2005) 106 (11): 4133.

https://doi.org/10.1182/blood.V106.11.4133.4133

Published: 2005

Journal Articles

ALG/ATG: illuminating the occult

David P. Steensma

Blood (2003) 102 (10): 3467–3468.

https://doi.org/10.1182/blood-2003-08-2937

Published: 2003

NARROW

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37 Targeted Radioimmunotherapy in Activated B Cell like Diffuse Large B Cell Lymphoma Cell Lines

The Transcription Repressor Gfi1 Directly Interacts With and Is Phosphorylated By Aurora A Kinase, Which Abrogates Myeloma-Induced Gfi1 Repression Of The Runx2 Promoter In Pre-Osteoblasts

The Transcription Repressor Gfi1 Directly Interacts With and Is Phosphorylated By Aurora A Kinase, Which Abrogates Myeloma-Induced Gfi1 Repression Of The Runx2 Promoter In Pre-Osteoblasts

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

Inhibition of Multiple Myeloma Tumor Growth and FGFR3 by the Aurora-Angiogenesis Inhibitor ENMD-981693.

Thrombophilic Patients with Migraines Have a High Incidence of Antiphospholipid Antibodies.

ALG/ATG: illuminating the occult

Email alerts

ASH Publications

American Society of Hematology

The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37 Targeted Radioimmunotherapy in Activated B Cell like Diffuse Large B Cell Lymphoma Cell Lines

The Transcription Repressor Gfi1 Directly Interacts With and Is Phosphorylated By Aurora A Kinase, Which Abrogates Myeloma-Induced Gfi1 Repression Of The Runx2 Promoter In Pre-Osteoblasts

The Transcription Repressor Gfi1 Directly Interacts With and Is Phosphorylated By Aurora A Kinase, Which Abrogates Myeloma-Induced Gfi1 Repression Of The Runx2 Promoter In Pre-Osteoblasts

Aurora Kinase Inhibition Enhances the Chemotherapy-Induced Myeloid Leukemia Cell Death through Different Mechanism According to the Chemotherapeutic Agents

Inhibition of Multiple Myeloma Tumor Growth and FGFR3 by the Aurora-Angiogenesis Inhibitor ENMD-981693.

Thrombophilic Patients with Migraines Have a High Incidence of Antiphospholipid Antibodies.

ALG/ATG: illuminating the occult

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only